Position in PFE
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$4,078,622
-$386,182 QoQ
Shares Held
169,378
+6.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#674
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2021CallValue
$5,905
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $209,939,553 across 14 Drug Manufacturers - General names. PFE ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
130,247 | $156,222,172 | |
| 2 | JNJ |
Johnson & Johnson
|
62,574 | $15,891,918 | |
| 3 | ABBV |
AbbVie Inc.
|
47,980 | $12,073,687 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,116 | $6,953,906 | |
| 5 | AMGN |
Amgen Inc
|
17,375 | $6,291,835 | |
| 6 | PFE |
Pfizer Inc
This page
|
169,378 | $4,078,622 | |
| 7 | AZN |
Astrazeneca PLC
|
9,817 | $1,861,499 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,784 | $1,716,154 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,078,622 | 169,378 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $4,464,804 | 159,003 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,437,453 | 178,211 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $4,650,329 | 182,509 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $4,540,394 | 187,310 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $4,758,345 | 187,780 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $5,377,763 | 202,705 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $6,302,842 | 217,790 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $6,077,507 | 217,209 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $5,328,832 | 192,030 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $5,168,755 | 179,533 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $6,418,328 | 193,498 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $8,029,985 | 218,920 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $8,641,195 | 211,794 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $10,924,624 | 213,205 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,719,661 | 199,261 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $10,092,512 | 192,495 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $10,808,437 | 208,778 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $11,526,441 | 195,198 | Shares | Sole | 2022-01-07 | |
| 2021-12-31 | $5,905 | 100 | Call | Sole | 2022-01-07 | |
| 2021-09-30 | $8,323,381 | 193,522 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $6,783,530 | 173,226 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $6,036,388 | 166,613 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $5,784,838 | 157,154 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,346,560 | 145,683 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $5,422,254 | 165,818 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $4,201,023 | 128,708 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||